CIPK3 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CIPK3 antibody; PKS12 antibody; SnRK3.17 antibody; At2g26980 antibody; T20P8.3CBL-interacting serine/threonine-protein kinase 3 antibody; EC 2.7.11.1 antibody; SNF1-related kinase 3.17 antibody; SOS2-like protein kinase PKS12 antibody
Target Names
CIPK3
Uniprot No.

Target Background

Function
CIPK3, a serine-threonine protein kinase, plays a role in enhancing resistance to abiotic stresses, such as high salt and hyperosmotic conditions, in young seedlings. This function is achieved by regulating the expression of stress-inducible genes, including those activated by cold and salt but excluding drought-responsive genes. Furthermore, CIPK3 is essential for the abscisic acid (ABA) response during germination. CIPK3 interacts with CBL proteins, a family of calcium sensor proteins, through a specific regulatory domain known as the NAF domain. The binding of a CBL protein to the NAF domain of CIPK3 activates the kinase in a calcium-dependent manner. Notably, the CBL9/CIPK3 complex plays a crucial role in regulating ABA responses during seed germination.
Gene References Into Functions
  1. The CBL9-CIPK3-ABR1 pathway regulates seed germination and ABA-dependent physiological processes in Arabidopsis. PMID: 27964784
  2. CBL9 and CIPK3 function together in the same pathway to regulate abscisic acid responses in Arabidopsis. PMID: 19825536
Database Links

KEGG: ath:AT2G26980

STRING: 3702.AT2G26980.4

UniGene: At.13161

Protein Families
Protein kinase superfamily, CAMK Ser/Thr protein kinase family, SNF1 subfamily
Tissue Specificity
Mostly expressed in germinating seeds and young seedlings. Detected at low levels in roots, stems, leaves and flowers.

Q&A

What is CIPK3 and why is it significant in plant research?

CIPK3 (CBL-Interacting Protein Kinase 3) is a serine-threonine protein kinase that plays crucial roles in calcium signaling and stress responses in plants. As a member of the CIPK gene family, it interacts with CBL (Calcineurin B-Like) calcium sensors to form complexes that regulate various physiological processes. CIPK3 is particularly significant because it acts as a regulatory component in abscisic acid (ABA) signaling pathways and is involved in plant responses to environmental stresses such as cold, drought, and salt conditions . The protein contains specific kinase domains that enable it to phosphorylate downstream targets, making it an important mediator in calcium-dependent signal transduction cascades. In Arabidopsis, CIPK3 is one of 26 identified CIPK genes, highlighting its place within a large and functionally diverse protein family that coordinates calcium signaling with stress adaptation mechanisms .

What cellular locations should I expect to detect CIPK3 when using antibodies?

When using CIPK3 antibodies for cellular localization studies, you should expect to detect signals primarily in the cytoplasm and nucleus. Fluorescent labeling experiments have revealed that GFP fusion proteins of CIPK3, along with several other CIPKs (including CIPK1, CIPK2, CIPK4, CIPK7, CIPK8, CIPK10, CIPK14, CIPK17, CIPK21, CIPK23, and CIPK24), exhibit significant fluorescence in both cytoplasmic and nuclear compartments . This dual localization pattern is consistent with CIPK3's role in transmitting calcium signals to various cellular targets. When designing immunolocalization experiments, researchers should include appropriate cytoplasmic and nuclear markers as controls and consider fixation methods that preserve both compartments effectively. It's worth noting that the subcellular localization of CIPK3 may change upon activation or in response to specific stress conditions, so experimental timing and conditions should be carefully controlled.

How are CIPK3 expression patterns altered under different stress conditions?

CIPK3 expression undergoes significant regulation in response to various environmental stresses. Under drought stress conditions, CIPK3 works in conjunction with CBL proteins to alter the sensitivity of ABA in guard cells, contributing to stomatal regulation and water conservation mechanisms . Cold stress notably activates CIPK3 expression, with the protein participating in cold tolerance response pathways .

When designing experiments to detect these expression changes using CIPK3 antibodies, researchers should:

  • Include appropriate time-course sampling (0h, 3h, 6h, 12h, 24h, 48h after stress application)

  • Compare multiple stress conditions in parallel (e.g., drought, salt, cold, heat)

  • Consider tissue-specific expression patterns (roots vs. shoots vs. reproductive tissues)

  • Use both transcript (RT-qPCR) and protein (Western blot with CIPK3 antibodies) analysis to capture post-transcriptional regulation

These expression patterns make CIPK3 an excellent marker for monitoring plant stress responses and for validating stress treatment efficacy in experimental systems.

What protein extraction methods are optimal for CIPK3 detection by Western blotting?

For optimal CIPK3 detection via Western blotting, protein extraction must preserve both phosphorylated and non-phosphorylated forms while minimizing degradation. Based on published phosphoproteomic studies of CIPK proteins, the following extraction protocol is recommended:

Table 1: Optimized Protein Extraction Buffer for CIPK3 Western Blotting

ComponentConcentrationPurpose
Tris-HCl (pH 7.5)50 mMMaintains neutral pH
NaCl150 mMProvides ionic strength
EDTA1 mMChelates metal ions
EGTA1 mMChelates calcium ions
NaF10 mMPhosphatase inhibitor
Na₃VO₄1 mMTyrosine phosphatase inhibitor
β-glycerophosphate25 mMSerine/threonine phosphatase inhibitor
Triton X-1000.1%Solubilizes membrane proteins
Protease inhibitor cocktailPrevents protein degradation
DTT1 mMReduces disulfide bonds

This extraction method is critical because CIPK3's activity and detection can be significantly affected by its phosphorylation state. When performing Western blotting, researchers should consider using Phos-tag™ SDS-PAGE to differentiate between phosphorylated and non-phosphorylated forms of CIPK3, as phosphorylation states may change dramatically under different experimental conditions . Additionally, flash-freezing tissues in liquid nitrogen before extraction and maintaining samples at 4°C throughout the extraction process will minimize proteolytic degradation and preserve post-translational modifications.

How can I validate the specificity of my CIPK3 antibody?

Validating CIPK3 antibody specificity is crucial for generating reliable research data. A comprehensive validation approach should include:

  • Positive and negative controls:

    • Use wild-type plant tissues known to express CIPK3 as positive controls

    • Include tissues from verified cipk3 knockout mutants as negative controls

    • Consider using cipk3/9/23/26 quadruple mutants to confirm the absence of cross-reactivity with closely related CIPK family members

  • Peptide competition assay:

    • Pre-incubate the antibody with excess synthetic peptide corresponding to the immunogen

    • Compare Western blot signals with and without peptide competition

    • Specific CIPK3 bands should disappear in the peptide-competed samples

  • Multiple detection methods:

    • Compare results from different techniques (Western blot, immunoprecipitation, immunohistochemistry)

    • Use antibodies targeting different epitopes of CIPK3 when available

    • Verify correlation between protein levels (antibody detection) and transcript levels (RT-qPCR)

  • Cross-reactivity assessment:

    • Test against recombinant CIPK family proteins (particularly CIPK9, CIPK23, and CIPK26)

    • Create a specificity table documenting signal intensity against different CIPK proteins

    • Consider using heterologous expression systems (e.g., E. coli, insect cells) to produce pure CIPK proteins

This multi-faceted validation strategy ensures that observed signals genuinely represent CIPK3 and not related proteins or non-specific binding.

What are the best fixation and permeabilization methods for CIPK3 immunolocalization?

For successful CIPK3 immunolocalization in plant tissues, fixation and permeabilization steps must preserve protein structure and epitope accessibility while maintaining cellular architecture. Based on the subcellular localization patterns of CIPK proteins in both cytoplasm and nucleus , the following protocol is recommended:

Fixation Protocol:

  • Fix fresh tissue samples in 4% paraformaldehyde in PBS (pH 7.4) for 2 hours at room temperature

  • For better nuclear preservation, include 0.1% glutaraldehyde in the fixative solution

  • After fixation, wash samples 3× in PBS for 10 minutes each

  • For storage, transfer to PBS containing 0.02% sodium azide (samples can be stored at 4°C for up to 1 week)

Permeabilization Options:

MethodProcedureBest ForLimitations
Triton X-1000.1-0.5% in PBS for 15-30 minGeneral cellular permeabilizationMay disrupt membrane proteins
Tween-200.05-0.1% in PBS for 10-20 minMilder membrane permeabilizationMay provide insufficient permeabilization for nuclear proteins
Methanol100% at -20°C for 10 minExcellent nuclear penetrationCan disrupt protein epitopes
EnzymaticCellulase (1%) + Pectinase (0.5%) in PBS for 30 minPlant cell wall digestionMay alter cell morphology

When targeting CIPK3 in both cytoplasmic and nuclear compartments, a sequential approach often works best: start with cell wall digestion using enzymatic treatment, followed by mild detergent permeabilization (0.1% Triton X-100). This combination enhances antibody penetration while preserving CIPK3 epitopes and cellular architecture.

How can phosphoproteomic approaches be used to study CIPK3 function and targets?

Phosphoproteomics provides powerful insights into CIPK3 function by revealing both its phosphorylation state and downstream phosphorylation targets. A comprehensive phosphoproteomic workflow for CIPK3 research includes:

  • Sample preparation with phosphorylation preservation:

    • Extract proteins using buffers containing phosphatase inhibitors (NaF, Na₃VO₄, β-glycerophosphate)

    • Perform tryptic digestion of proteins to generate peptides

    • Enrich phosphopeptides using IMAC (Immobilized Metal Affinity Chromatography) or TiO₂ (Titanium Dioxide) methods

  • Quantitative phosphoproteomics:

    • Apply TMT (Tandem Mass Tag) labeling for multiplexed quantitative comparison

    • Separate peptides using high-pH reversed-phase HPLC fractionation

    • Analyze samples using LC-MS/MS on high-resolution instruments (e.g., Q Exactive Plus)

  • Data analysis and interpretation:

    • Identify phosphorylation sites using database search algorithms (e.g., MaxQuant, Proteome Discoverer)

    • Perform statistical analysis using methods like principal component analysis and Pearson's correlation coefficient

    • Conduct GO enrichment analysis to identify biological processes affected by CIPK3

This approach has been successfully applied to study cipk3/9/23/26 quadruple mutants, revealing differential phosphorylation of proteins involved in various cellular processes including chloroplast relocation, establishment of plastid localization, and response to magnesium levels . When comparing wild-type and cipk3 mutant plants, researchers can identify direct and indirect targets of CIPK3 kinase activity, providing functional insights beyond what antibody-based approaches alone can achieve.

What are the molecular mechanisms underlying CIPK3's role in magnesium homeostasis?

CIPK3, along with CIPK9, CIPK23, and CIPK26, plays a crucial role in maintaining magnesium (Mg²⁺) homeostasis in plants. Phosphoproteomic studies of the cipk3/9/23/26 quadruple mutant have revealed the molecular mechanisms involved:

  • Vacuolar sequestration pathway:

    • CBL calcium sensors (particularly CBL2 and CBL3) detect calcium signals

    • These CBLs recruit and activate CIPK3 and related kinases

    • Activated CIPKs phosphorylate Mg²⁺ transport systems

    • This phosphorylation enhances Mg²⁺ transport into vacuoles, preventing cytoplasmic toxicity

  • Proton gradient disruption:

    • The cipk3/9/23/26 quadruple mutant shows downregulation of V-type proton ATPase subunits

    • This disrupts the tonoplast membrane potential and proton gradient

    • The resulting ion transport imbalance leads to elevated cytoplasmic Mg²⁺ levels

    • High cytoplasmic Mg²⁺ causes growth retardation and chlorosis in leaf tips

  • Chlorophyll synthesis impact:

    • Mg-chelatase subunit CHLI-1 is downregulated in the cipk3/9/23/26 quadruple mutant

    • This affects chlorophyll synthesis, explaining the chlorosis phenotype

    • The effect demonstrates how CIPK3's role in ion homeostasis extends to influence photosynthetic capacity

When using CIPK3 antibodies to study these mechanisms, researchers should:

  • Compare CIPK3 phosphorylation states under normal and high Mg²⁺ conditions

  • Examine CIPK3 localization to determine if it shifts toward the tonoplast under Mg²⁺ stress

  • Investigate co-immunoprecipitation of CIPK3 with Mg²⁺ transporters to identify direct interactions

This understanding of CIPK3's role in Mg²⁺ homeostasis highlights the importance of this kinase in maintaining ion balance and preventing metal toxicity.

How does CIPK3 integrate with other signaling pathways in abiotic stress responses?

CIPK3 functions as a critical node in a complex network of signaling pathways that orchestrate plant responses to abiotic stresses. Understanding these integration points is essential for interpreting CIPK3 antibody data in stress response studies:

How can I address weak or non-specific signals when using CIPK3 antibodies in Western blotting?

When encountering weak or non-specific signals in CIPK3 Western blots, a systematic troubleshooting approach can resolve most issues:

For weak signals:

  • Protein extraction optimization:

    • Ensure complete extraction by using appropriate buffer-to-tissue ratios (typically 3-5 mL buffer per gram of tissue)

    • Include phosphatase inhibitors (10 mM NaF, 1 mM Na₃VO₄) to preserve phosphorylated forms

    • Consider using a stronger lysis buffer containing 1% SDS for more complete extraction

  • Antibody conditions adjustment:

    • Increase primary antibody concentration (try 1:500 instead of 1:1000)

    • Extend primary antibody incubation time (overnight at 4°C instead of 2 hours)

    • Use a more sensitive detection system (enhanced chemiluminescence or fluorescence-based detection)

  • Protein loading and transfer optimization:

    • Increase protein loading (50-100 μg per lane)

    • Reduce transfer time or voltage for large proteins

    • Use PVDF membranes instead of nitrocellulose for better protein retention

For non-specific signals:

  • Blocking optimization:

    • Try different blocking agents (5% BSA often works better than milk for phosphoprotein detection)

    • Extend blocking time (2 hours at room temperature or overnight at 4°C)

    • Add 0.1% Tween-20 to all washing and antibody incubation steps

  • Antibody specificity measures:

    • Pre-absorb antibody with recombinant proteins from related CIPK family members

    • Use higher stringency wash conditions (increase salt concentration to 250-500 mM NaCl)

    • Perform a peptide competition assay to confirm band specificity

  • Sample preparation considerations:

    • Ensure complete denaturation of proteins (boil samples for 5 minutes in SDS sample buffer)

    • Add protein phosphatase inhibitors to prevent dephosphorylation during extraction

    • Use freshly prepared samples whenever possible

By systematically addressing these potential issues, researchers can significantly improve the specificity and sensitivity of CIPK3 detection in Western blotting applications.

What controls should I include when studying CIPK3 phosphorylation status?

Studying CIPK3 phosphorylation status requires careful experimental design and appropriate controls to ensure reliable results:

Essential controls for CIPK3 phosphorylation studies:

  • Genetic controls:

    • Wild-type plants expressing normal levels of CIPK3 (positive control)

    • cipk3 knockout mutants (negative control for specificity)

    • Phospho-dead mutants (CIPK3 with key phosphorylation sites mutated to alanine)

    • Phospho-mimetic mutants (CIPK3 with key phosphorylation sites mutated to aspartate or glutamate)

  • Treatment controls:

    • Phosphatase treatment: Divide sample and treat half with lambda phosphatase to remove phosphorylation

    • Kinase activator/inhibitor: Compare samples treated with calcium (activates CBL-CIPK pathway) vs. calcium channel blockers

    • Time course samples: Collect tissues at multiple time points after stress application to capture dynamic phosphorylation changes

  • Technical controls:

    • Phos-tag™ gel electrophoresis: Run parallel samples on standard and Phos-tag™ gels to visualize mobility shifts

    • Phospho-specific antibodies: Use antibodies that specifically recognize phosphorylated forms of CIPK3

    • Loading controls: Include constitutively expressed proteins that are not affected by the treatments

Example experimental design for CIPK3 phosphorylation study:

SampleTreatmentGenetic BackgroundPhosphatase TreatmentExpected Outcome
1ControlWild-typeNoBaseline phosphorylation
2ControlWild-typeYesDephosphorylated control
3Controlcipk3 mutantNoNegative control
4StressWild-typeNoStress-induced phosphorylation
5StressWild-typeYesConfirmation of phosphorylation
6Stresscipk3 mutantNoSpecificity control

This comprehensive control strategy allows researchers to confidently interpret changes in CIPK3 phosphorylation status and distinguish genuine phosphorylation events from artifacts or non-specific signals.

How can I optimize co-immunoprecipitation protocols to study CIPK3 protein interactions?

Co-immunoprecipitation (Co-IP) is a powerful technique for studying CIPK3 protein interactions, but requires optimization to capture physiologically relevant complexes. The following protocol enhancements can significantly improve Co-IP results:

Optimized Co-IP Protocol for CIPK3 Interaction Studies:

  • Buffer optimization:

    • Use a gentle lysis buffer to preserve protein-protein interactions:

      • 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA

      • 0.5-1% NP-40 or 0.5% Triton X-100 (avoid stronger detergents like SDS)

      • 10% glycerol to stabilize protein complexes

      • Protease and phosphatase inhibitor cocktails

    • For detecting calcium-dependent interactions, carefully control calcium levels:

      • For calcium-free conditions: add 5 mM EGTA

      • For calcium-present conditions: add 1 mM CaCl₂

  • Cross-linking considerations:

    • For transient interactions, consider mild cross-linking with 0.5-1% formaldehyde for 10 minutes

    • For membrane-associated complexes, use membrane-permeable cross-linkers like DSP (dithiobis(succinimidyl propionate))

    • Include a non-cross-linked control to assess specificity

  • Immunoprecipitation strategy:

    • Pre-clear lysates with protein A/G beads to reduce non-specific binding

    • Use antibody-conjugated magnetic beads for cleaner precipitation and easier washing

    • Incubate overnight at 4°C with gentle rotation to maximize interaction capture

    • Perform at least 5 washes with decreasing salt concentrations (from 300 mM to 150 mM NaCl)

  • Elution and detection optimization:

    • Use competitive elution with excess immunizing peptide for gentler elution

    • For cross-linked samples, reverse cross-links before SDS-PAGE

    • Consider on-bead digestion followed by mass spectrometry for unbiased interaction partner identification

    • For Western blot detection, use highly specific secondary antibodies and optimize exposure times

Table 3: Troubleshooting Co-IP Issues with CIPK3 Antibodies

ProblemPossible CauseSolution
No CIPK3 detection after IPEpitope masked by interaction partnersTry antibodies targeting different CIPK3 epitopes
No interaction partners detectedWashing conditions too stringentReduce salt concentration in wash buffers
Non-specific bands overwhelming signalInsufficient blocking or pre-clearingIncrease pre-clearing time and use 5% BSA for blocking
Inconsistent results between replicatesVariable CIPK3 expression/activationStandardize tissue collection and stress treatment timing
Interaction only seen in vitro, not in vivoPhysiological relevance issueUse in vivo cross-linking before tissue harvesting

By optimizing these parameters for CIPK3-specific co-immunoprecipitation, researchers can reliably identify and characterize interaction partners, including CBL calcium sensors, target substrates, and regulatory proteins that modulate CIPK3 function in stress responses and magnesium homeostasis.

How can CIPK3 antibodies be used in high-throughput phenotyping systems?

CIPK3 antibodies offer significant potential for integration into high-throughput phenotyping platforms that monitor plant stress responses. Implementing this approach requires:

  • Antibody-based biosensor development:

    • Immobilize CIPK3 antibodies on microarray surfaces or biosensor chips

    • Couple with fluorescence or electrical impedance detection systems

    • Create calibration curves using purified CIPK3 protein standards at known concentrations

    • Validate sensitivity and specificity across multiple plant species and tissues

  • Automated tissue processing:

    • Develop standardized protein extraction protocols compatible with robotic handling systems

    • Create multiplexed detection systems to simultaneously monitor CIPK3 and other stress markers

    • Implement machine learning algorithms to correlate CIPK3 levels with phenotypic outcomes

    • Establish quality control metrics to ensure consistent antibody performance across batches

  • Integration with phenomics platforms:

    • Correlate CIPK3 protein levels and phosphorylation states with:

      • Plant growth parameters (height, biomass, root architecture)

      • Physiological measurements (photosynthetic efficiency, stomatal conductance)

      • Stress response indicators (ROS production, membrane integrity)

    • Develop temporal modeling to capture dynamic CIPK3 responses during stress progression

This approach would enable researchers to screen large populations of plants for stress resilience mechanisms mediated by CIPK3, accelerating breeding programs and functional genomics studies in crop improvement initiatives.

What insights do cipk3 mutant studies provide for targeted antibody applications?

Studies of cipk3 single mutants and cipk3/9/23/26 quadruple mutants have revealed specific phenotypes and molecular mechanisms that inform targeted antibody applications:

  • Magnesium homeostasis research:

    • The cipk3/9/23/26 quadruple mutant exhibits severe growth retardation and leaf tip chlorosis under high Mg²⁺ conditions

    • CIPK3 antibodies can be used to monitor protein levels and localization during Mg²⁺ stress

    • Phospho-specific antibodies targeting CIPK3 activation sites would help determine when and where CIPK3 becomes activated during ion stress

  • Stress signaling network analysis:

    • CIPK3 modulates ABA sensitivity and stress-responsive gene expression

    • Antibodies can help map the temporal sequence of CIPK3 activation in relation to other signaling components

    • Co-localization studies using CIPK3 antibodies with markers for different cellular compartments can reveal trafficking patterns during stress response

  • Protein-protein interaction studies:

    • CIPK3 interacts with multiple CBL calcium sensors and downstream targets

    • Proximity ligation assays using CIPK3 antibodies can visualize these interactions in situ

    • Pull-down experiments with CIPK3 antibodies followed by mass spectrometry can identify novel interaction partners

Table 4: Phenotypes in cipk3 Mutants and Corresponding Antibody Applications

Mutant PhenotypeMolecular MechanismTargeted Antibody Application
Altered ABA responses Modified ABA signal transductionMonitor CIPK3 phosphorylation status during ABA treatment
Cold stress sensitivity Disrupted cold signaling cascadeTrack CIPK3 subcellular relocalization during temperature shifts
Mg²⁺ toxicity susceptibility Impaired vacuolar sequestrationExamine CIPK3-transporter interactions at the tonoplast
Changes in phosphoproteome Altered downstream target phosphorylationUse phospho-specific antibodies to monitor substrate activation

By aligning antibody-based approaches with known mutant phenotypes, researchers can develop targeted strategies to elucidate CIPK3 function in specific physiological contexts.

How will advances in proteomics technology influence future CIPK3 antibody research?

Emerging proteomics technologies are poised to transform CIPK3 antibody research in several key areas:

  • Single-cell proteomics integration:

    • Next-generation mass spectrometry with increased sensitivity will enable CIPK3 detection at the single-cell level

    • CIPK3 antibodies can be used for cell sorting prior to single-cell proteomic analysis

    • This will reveal cell-type specific CIPK3 functions that may be masked in whole-tissue studies

    • Researchers will need to optimize antibody specificity for compatibility with single-cell isolation techniques

  • Spatial proteomics advancement:

    • Mass spectrometry imaging (MSI) combined with CIPK3 immunolabeling will map protein distribution across tissues

    • Multiplexed ion beam imaging (MIBI) will allow simultaneous detection of CIPK3 and dozens of interaction partners

    • These approaches will reveal micro-domains of CIPK3 activity within cells and tissues

    • Development of antibodies compatible with tissue preservation techniques used in spatial proteomics will be crucial

  • Structural proteomics integration:

    • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) with CIPK3 antibodies will reveal conformational changes

    • Cross-linking mass spectrometry (XL-MS) will map interaction interfaces between CIPK3 and partners

    • Cryo-electron microscopy of immunoprecipitated complexes will visualize CIPK3 in native assemblies

    • These approaches will require antibodies that recognize specific conformational states of CIPK3

  • Temporal dynamics analysis:

    • Pulse-chase proteomics combined with CIPK3 immunoprecipitation will track protein turnover rates

    • Antibody-based biosensors will monitor real-time changes in CIPK3 levels or phosphorylation

    • Microfluidic platforms with integrated antibody detection will capture rapid signaling events

    • These applications will demand antibodies with consistent performance under diverse experimental conditions

As these technologies mature, CIPK3 antibody applications will expand beyond traditional Western blotting and immunoprecipitation to provide unprecedented insights into the dynamic behavior of this important signaling protein in response to environmental stresses.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.